New Mexico Governor Michelle Lujan Grisham said her state may pursue billions of dollars in civil damages from the Drug Enforcement Administration, escalating a dispute that has pitted state leaders against the federal agency. The threat came after last week's revelation that federal agents allowed hundreds of thousands of fentanyl pills to reach the streets of Albuquerque rather than removing them from circulation.
At the center of the controversy is an account from a DEA whistleblower, David Howell, who spoke with United Press. According to Howell, agents chose not to seize the pills in an effort to pursue larger drug trafficking cases, effectively prioritizing a bigger investigation over taking the narcotics off the street. The disclosure has fueled anger among state officials who say residents were put at risk.
Lujan Grisham described the situation as an outrage and vowed to shield residents from a repeat of the practice, framing the issue as one of protecting the public from federal operations that, in her view, traded community safety for investigative gains. She signaled that the state would use every available tool to hold the responsible parties to account.
The governor laid out a series of demands aimed at preventing similar operations in the future. She called for state legislation that would prohibit such tactics within New Mexico, and urged federal lawmakers to bar these practices across federal law enforcement jurisdictions so that no agency could run comparable operations elsewhere in the country.
She also pressed Washington on funding, arguing that the federal government should fully fund the law enforcement activities and public safety supports needed to meet local demand. As part of that, the governor said the feds owe the state roughly 25 million dollars and should pay it back, tying the financial claim to the broader push for accountability.
The political pressure is accompanied by a legal track. New Mexico's Attorney General has launched a criminal investigation of the DEA, opening the possibility of formal findings against the agency. The combination of a potential civil claim, demands for new legislation and a criminal inquiry points to a sustained confrontation between state and federal authorities.
The case raises pointed questions about the methods used by federal agents in the fight against the fentanyl trade, where the choice between immediate seizures and longer-term investigations can carry serious consequences for communities. For New Mexico, which has been hit hard by the opioid crisis, the revelation that pills were allowed to circulate has turned a law enforcement decision into a major accountability fight.